757024

213326

ACCPL

img img img img
No Data Available

ACCRETION PHARMA LIMITED Share Price Update

As of the latest trading session, ACCRETION PHARMA LIMITED share price is currently at ₹68.5, which is up by ₹0.00 from its previous closing. Today, the stock has fluctuated between ₹68.50 and ₹68.50. Over the past year, ACCRETION PHARMA LIMITED has achieved a return of -17.42%. In the last month alone, the return has been -6.10%.

ACCRETION PHARMA LIMITED performance

Today’s low

Today’s high

₹ 68.50 ₹ 68.50
₹ 68.50

52 week low

52 week high

₹ 53.80 ₹ 102.50
₹ 68.50

Open Price

₹ 68.50

Prev. Close

₹ 68.50

Volume (Shares)

4800.00

Total traded value

₹ 3.28

Upper Circuit

₹ 71.90

Lower Circuit

₹ 65.10

info

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ACCRETION PHARMA LIMITED fundamentals


  • Market cap (Cr)

    76.10

  • P/E Ratio (TTM)

    11.21

  • Beta

    0.65

  • Book Value / share

    40.51

  • Return on equity

    65.35%

  • EPS (TTM)

    6.11

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text
  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text

ACCRETION PHARMA LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 57.38
Operating Expense 47.71
Net Profit 6.79
Net Profit Margin (%) 11.83
Earnings Per Share (EPS) 8.48
EBITDA 11.96
Effective Tax Rate (%) 30.43
Particulars MAR 2024 (Values in Cr)
Revenue 13.35
Operating Expense 11.41
Net Profit 1.49
Net Profit Margin (%) 11.16
Earnings Per Share (EPS) 1.96
EBITDA 2.62
Effective Tax Rate (%) 25.00
Particulars MAR 2023 (Values in Cr)
Revenue 29.38
Operating Expense 29.40
Net Profit 0.10
Net Profit Margin (%) 0.34
Earnings Per Share (EPS) 0.27
EBITDA 2.14
Effective Tax Rate (%) 21.42
Particulars MAR 2022 (Values in Cr)
Revenue 22.29
Operating Expense 22.48
Net Profit 0.08
Net Profit Margin (%) 0.35
Earnings Per Share (EPS) 0.25
EBITDA 1.93
Effective Tax Rate (%) 30.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 18.71
ROE % 65.35
ROCE % 46.32
Total Debt to Total Equity 1.33
EBITDA Margin 20.88
Particulars MAR 2024 (Values in Cr)
Book Value / Share 13.73
ROE % 27.14
ROCE % 12.60
Total Debt to Total Equity 2.46
EBITDA Margin 19.63
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 39.87
Total Liabilities 39.87
Total Equity 15.28
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 17.03
Return on Capital (%) 23.12
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 27.43
Total Liabilities 27.43
Total Equity 5.49
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 5.44
Return on Capital (%) 7.87
Particulars MAR 2025 (Values in Cr)
Net Income 9.76
Cash from Operations 7.60
Cash from Investing -1.61
Cash from Financing -4.18
Net change in Cash -0.04
Free Cash Flow 9.21
Particulars MAR 2024 (Values in Cr)
Net Income 1.99
Cash from Operations -12.29
Cash from Investing -5.47
Cash from Financing 17.07
Net change in Cash 0.09
Free Cash Flow -6.81
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 28.58 12.37 1.48 219.02 23.12 / 52.00
BLISS GVS PHARMA LTD 217.80 20.82 2.03 2304.08 105.05 / 225.00
CIPLA LTD 1330.85 22.61 3.26 107503.49 1283.00 / 1672.20
FERMENTA BIOTECH LIMITED 310.90 10.34 2.34 915.01 219.00 / 399.00
GLAXOSMITHKLINE PHARMA LT 2593.90 43.69 25.73 43942.23 1968.00 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 28.58 23.24 3.98 219.02 23.12 / 52.00
AMRUTAJAN HEALTH LTD 632.15 31.61 5.34 1827.59 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8878.75 106.70 27.78 22196.88 6501.60 / 10653.05
BLISS GVS PHARMA LTD 217.80 29.67 2.08 2304.08 105.05 / 225.00

ACCRETION PHARMA LIMITED shareholding pattern

Holding

26.48%
73.51%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

ACCRETION PHARMA LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
68.50 0.00 redarrow
red-green-graph indicator
4 Bearish
12 Bullish
  • 5 Days 68.30
  • 26 Days 71.20
  • 10 Days 68.60
  • 50 Days 73.50
  • 12 Days 68.80
  • 100 Days 73.10
  • 20 Days 70.10
  • 200 Days 69.30
68.50 PIVOT

First Support

68.50

First Resistance

68.50

Second Support

68.50

Second Resistance

68.50

Third Support

68.50

Third Resistance

68.50

RSI

43.28

ADX

50.67

MACD

-2.46

Williams % R

-51.35

Commodity Channel Index (CCI)

8.62

Date

2026-02-13

Week

9600.00

Same Day

4800.00

Month

10527.00

1 Year

0.65

3 Year

0.65

Over 1 Month

-6.10%

down

Over 1 Year

-17.42%

down

Over 3 Months

3.55%

down

Over 3 Years

0.00%

down

Over 6 Months

15.80%

down

Over 5 Years

0.00%

down

ACCRETION PHARMA LIMITED Corporate Actions

Top Gainers

ACCRETION PHARMA LIMITED Share Price

Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products. Thus, the foundation of 'Accretion Pharmaceuticals' was laid down, which was started as a Partnership Firm in the name of 'M/s Accretion Pharmaceuticals', pursuant to a deed of partnership dated December 18, 2012.

The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in 2014. Thereafter, the Partnership Firm was converted into a Limited Company in the name of 'Accretion Pharmaceuticals Limited' and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.

Presently, Company is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), And Oral Powder (Sachet, Dry Syrup) etc. either for direct sales, loan licence and/or contract manufacturing.

The Company is ISO 9001:2015, ISO 14001:2015 and ISO 22000:2018 certified and is led by a experienced board of directors, and a professional and experienced management team with extensive experience in the pharmaceutical.

The Company issued and allotted 29,46,000 equity shares of Rs 10 each by raising Rs 29.75 crores in May, 2025.

Parent organization Indian Private
NSE symbol ACCPL
Founded 2023
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Accretion Pharmaceuticals Ltd?

Answer Field

Accretion Pharmaceuticals Ltd share price is for NSE ₹ 68.50 & for BSE ₹ 0.00 as on Feb 13 2026 02:14 PM.

What is the Market Cap of Accretion Pharmaceuticals Ltd Share?

Answer Field

The market cap of Accretion Pharmaceuticals Ltd for NSE ₹ 76.10 & for BSE ₹ 0.00 as on Feb 13 2026 02:14 PM.

What is the 52 Week High and Low of Accretion Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Accretion Pharmaceuticals Ltd for NSE is ₹ 102.50 and ₹ 53.80 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Accretion Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -17.42%.

What is the P/E Ratio of Accretion Pharmaceuticals Ltd Share?

Answer Field

As on Feb 13 2026 02:14 PM the price-to-earnings (PE) ratio for Accretion Pharmaceuticals Ltd share is 11.21.

What is the PB ratio of Accretion Pharmaceuticals Ltd Share?

Answer Field

As on Feb 13 2026 02:14 PM, the price-to-book (PB) ratio for Accretion Pharmaceuticals Ltd share is 40.51.

How to Buy Accretion Pharmaceuticals Ltd Share?

Answer Field

You can trade in Accretion Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Accretion Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Accretion Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Accretion Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59